Gonzalez RC - Search Results

1

Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.

Hintzsche JD, Gorden NT, Amato CM, Kim J, Wuensch KE, Robinson SE, Applegate AJ, Couts KL, Medina TM, Wells KR, Wisell JA, McCarter MD, Box NF, Shellman YG, Gonzalez RC, Lewis KD, Tentler JJ, Tan AC, Robinson WA. Hintzsche JD, et al. Among authors: gonzalez rc. Melanoma Res. 2017 Jun;27(3):189-199. doi: 10.1097/CMR.0000000000000345. Melanoma Res. 2017. PMID: 28296713 Free PMC article.

2

A young woman with melanoma diagnosed during pregnancy.

Lewis KD, Gonzalez R, Robinson WA, Fitzpatrick JE, McCarter MD, Braden C. Lewis KD, et al. Oncology (Williston Park). 2004 Jun;18(7):794-9. Oncology (Williston Park). 2004. PMID: 15255167 No abstract available.

3

Identifying risk factors for complications following sentinel lymph node biopsy for melanoma.

Roaten JB, Pearlman N, Gonzalez R, Gonzalez R, McCarter MD. Roaten JB, et al. Arch Surg. 2005 Jan;140(1):85-9. doi: 10.1001/archsurg.140.1.85. Arch Surg. 2005. PMID: 15655211

4

Sentinel lymph node biopsy for melanoma and other melanocytic tumors in adolescents.

Roaten JB, Partrick DA, Pearlman N, Gonzalez RJ, Gonzalez R, McCarter MD. Roaten JB, et al. J Pediatr Surg. 2005 Jan;40(1):232-5. doi: 10.1016/j.jpedsurg.2004.09.022. J Pediatr Surg. 2005. PMID: 15868590

5

Survival in sentinel lymph node-positive pediatric melanoma.

Roaten JB, Partrick DA, Bensard D, Pearlman N, Gonzalez R, Fitzpatrick J, McCarter MD. Roaten JB, et al. J Pediatr Surg. 2005 Jun;40(6):988-92; discussion 992. doi: 10.1016/j.jpedsurg.2005.03.014. J Pediatr Surg. 2005. PMID: 15991183

6

A phase II study of biochemotherapy for advanced melanoma incorporating temozolomide, decrescendo interleukin-2 and GM-CSF.

Lewis KD, Gibbs P, O'Day S, Richards J, Weber J, Anderson C, Zeng C, Baron A, Russ P, Gonzalez R. Lewis KD, et al. Cancer Invest. 2005;23(4):303-8. doi: 10.1081/cnv-58832. Cancer Invest. 2005. PMID: 16100942 Clinical Trial.

7

Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.

Koyanagi K, O'Day SJ, Gonzalez R, Lewis K, Robinson WA, Amatruda TT, Wang HJ, Elashoff RM, Takeuchi H, Umetani N, Hoon DS. Koyanagi K, et al. J Clin Oncol. 2005 Nov 1;23(31):8057-64. doi: 10.1200/JCO.2005.02.0958. J Clin Oncol. 2005. PMID: 16258104 Free PMC article.

8

A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma.

Lewis KD, Thompson JA, Weber JS, Robinson WA, O'Day S, Lutzky J, Legha SS, Floret S, Ruvuna F, Gonzalez R. Lewis KD, et al. Invest New Drugs. 2006 Jan;24(1):89-94. doi: 10.1007/s10637-005-4544-y. Invest New Drugs. 2006. PMID: 16379038 Clinical Trial.

9

Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients.

Koyanagi K, O'Day SJ, Gonzalez R, Lewis K, Robinson WA, Amatruda TT, Kuo C, Wang HJ, Milford R, Morton DL, Hoon DS. Koyanagi K, et al. Clin Cancer Res. 2006 Feb 15;12(4):1137-43. doi: 10.1158/1078-0432.CCR-05-1847. Clin Cancer Res. 2006. PMID: 16489066 Free PMC article.

10

Lymphangiomatosis masquerading as metastatic melanoma.

Qutub W, Lewis K, Gonzalez R, Quaife R, Russ P, McCarter M. Qutub W, et al. Am Surg. 2006 Apr;72(4):367-70. Am Surg. 2006. PMID: 16676867 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

163 results

Search Page